Health & Biosciences — Segment Adjusted Operating EBITDA
International Flavors & Fragrances Health & Biosciences — Segment Adjusted Operating EBITDA decreased by 1.3% to $153.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.9%, from $138.00M to $153.00M. Over 3 years (FY 2022 to FY 2025), Health & Biosciences — Segment Adjusted Operating EBITDA shows relatively stable performance with a -2.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates improved operational efficiency and stronger segment-level profitability.
Detailed definition
A measure of the Health & Biosciences segment's operating profitability, excluding interest, taxes, depreciation, amorti...
Peer comparison
Commonly reported as 'Segment Adjusted EBITDA' by diversified industrial and specialty chemical peers.
iff_segment_health_biosciences_segment_adjusted_operating_ebitdaHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $190.00M | $151.00M | $192.00M | $184.00M | $137.00M | $121.00M | $131.00M | $145.00M | $150.00M | $98.00M | $138.00M | $151.00M | $152.00M | $136.00M | $138.00M | $151.00M | $150.00M | $155.00M | $153.00M |
| QoQ Change | — | -20.5% | +27.2% | -4.2% | -25.5% | -11.7% | +8.3% | +10.7% | +3.4% | -34.7% | +40.8% | +9.4% | +0.7% | -10.5% | +1.5% | +9.4% | -0.7% | +3.3% | -1.3% |
| YoY Change | — | — | — | -3.2% | -9.3% | — | -31.8% | -21.2% | +9.5% | -19.0% | +5.3% | +4.1% | +1.3% | +38.8% | +0.0% | +0.0% | -1.3% | +14.0% | +10.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is International Flavors & Fragrances's health & biosciences — segment adjusted operating ebitda?
- International Flavors & Fragrances (IFF) reported health & biosciences — segment adjusted operating ebitda of $153.00M in Q1 2026.
- How has International Flavors & Fragrances's health & biosciences — segment adjusted operating ebitda changed year-over-year?
- International Flavors & Fragrances's health & biosciences — segment adjusted operating ebitda increased by 10.9% year-over-year, from $138.00M to $153.00M.
- What is the long-term trend for International Flavors & Fragrances's health & biosciences — segment adjusted operating ebitda?
- Over 3 years (2022 to 2025), International Flavors & Fragrances's health & biosciences — segment adjusted operating ebitda has grown at a -2.1% compound annual growth rate (CAGR), from $634.00M to $594.00M.
- What does health & biosciences — segment adjusted operating ebitda mean?
- The core operating profit of the Health & Biosciences segment before non-cash and non-operating expenses.